Zim (ZIMCF) Net Income From Continuing Operations: $-0.20 Mil (TTM As of Sep. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Zim Net Income From Continuing Operations?

Zim ZIMCF Net Income From Continuing Operations is $-0.20 Mil as of Sep. 2021.

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Zim's net income from continuing operations for the three months ended in Sep. 2021 was $-0.07 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.20 Mil.

Zim Net Income From Continuing Operations Historical Data

* Premium members only.

The historical data trend for Zim's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zim Net Income From Continuing Operations Chart

Zim Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.04 0.70 -0.01 -0.08

Zim Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Jun21 Sep21
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 -0.07 -0.04 -0.05 -0.07

Zim Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income From Continuing Operations of $-0.20 Mil mean?
Zim (ZIMCF) has a Net Income From Continuing Operations of $-0.20 Mil as of Sep. 2021. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for Zim and its competitors.
Is Zim's Net Income From Continuing Operations too high?
Zim's current Net Income From Continuing Operations is $-0.20 Mil.
How does Zim's Net Income From Continuing Operations compare to MAPT and FSSN?
Zim's Net Income From Continuing Operations of $-0.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income From Continuing Operations for a Biotechnology company?
A good Net Income From Continuing Operations depends on the Biotechnology industry context. However, Net Income From Continuing Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income From Continuing Operations mean?
A high Net Income From Continuing Operations can signal that a stock is expensive relative to its fundamentals. The total net income from continuing operations as record on a company's cash-flow statement. View historical data for Zim and its competitors. Zim's current Net Income From Continuing Operations is $-0.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zim stock overvalued right now?
Zim (ZIMCF) has a current Net Income From Continuing Operations of $-0.20 Mil. The current Net Income From Continuing Operations is $-0.20 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income From Continuing Operations calculated?
Net Income From Continuing Operations is calculated from a company's financial statements. For Zim (ZIMCF), the current Net Income From Continuing Operations is $-0.20 Mil as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zim Business Description

Address 20 Colonade Road, Suite 200, Ottawa, ON, CAN, K2E 7M2
Zim Corp has sold its operations and is currently focused on biomedical research. The company focused all of its resources on developing intellectual property and advancing research and development in the areas of new synthetic drugs and immunotherapies. It generates geographic revenue from Canada.